Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Asset Writedowns and Impairment (2017 - 2025)

Dentsply Sirona (XRAY) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $37.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 84.26% year-over-year to $37.0 million, compared with a TTM value of $120.0 million through Dec 2025, down 50.21%, and an annual FY2025 reading of $125.0 million, down 48.13% over the prior year.
  • Asset Writedowns and Impairment was $37.0 million for Q4 2025 at Dentsply Sirona, up from $4.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $235.0 million in Q4 2024 and bottomed at $2.0 million in Q3 2023.
  • Average Asset Writedowns and Impairment over 4 years is $46.9 million, with a median of $6.0 million recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 66.67% in 2023, then crashed 84.26% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $6.0 million in 2022, then crashed by 66.67% to $2.0 million in 2023, then skyrocketed by 11650.0% to $235.0 million in 2024, then plummeted by 84.26% to $37.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for XRAY at $37.0 million in Q4 2025, $4.0 million in Q3 2025, and $79.0 million in Q2 2025.